Peyvandi, F., Breems, D.A., Knoebl, P., De Man, C., Wu, K.L., Lyssens, C. and Holz, J.B. (2011) First results of the phase II TITAN trial: Anti-von Willebrand factor nanobody as adjunctive treatment for patients with acquired thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis, 9, 720-721.

相关文章:
在线客服:
对外合作:
联系方式:400-6379-560
投诉建议:feedback@hanspub.org
客服号

人工客服,优惠资讯,稿件咨询
公众号

科技前沿与学术知识分享